Tenofovir disoproxil fumarateLack of efficacy in hepatitis B leading to acute hepatitis: case report

被引：0
作者：
机构：
来源：
Reactions Weekly | 2011年 / 1347卷 / 1期
关键词：
Hepatitis; Myocardial Infarction; Virus Infection; Congenital Anomaly; Clopidogrel;
D O I：
10.2165/00128415-201113470-00129
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：38 / 38
相关论文
共 50 条
  • [31] ClobenzorexFirst report of acute hepatitis: case report
    Reactions Weekly, 2003, 937 (1) : 7 - 8
  • [32] RofecoxibFirst report of acute hepatitis: case report
    Reactions Weekly, 2002, 925 (1) : 10 - 11
  • [33] ColchicineFirst report of acute hepatitis: case report
    Reactions Weekly, 2003, 980 (1) : 9 - 9
  • [34] Randomised clinical trial: 48 weeks of treatment with tenofovir amibufenamide versus tenofovir disoproxil fumarate for patients with chronic hepatitis B
    Liu, Zhihong
    Jin, Qinglong
    Zhang, Yuexin
    Gong, Guozhong
    Wu, Guicheng
    Yao, Lvfeng
    Wen, Xiaofeng
    Gao, Zhiliang
    Huang, Yan
    Yang, Daokun
    Chen, Enqiang
    Mao, Qing
    Lin, Shide
    Shang, Jia
    Gong, Huanyu
    Zhong, Lihua
    Yin, Huafa
    Wang, Fengmei
    Hu, Peng
    Xiao, Ling
    Li, Chuan
    Wu, Qiong
    Sun, Chang'an
    Niu, Junqi
    Hou, Jinlin
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (09) : 1134 - 1149
  • [35] MontelukastCytolytic acute hepatitis: case report
    Reactions Weekly, 2003, 966 (1) : 13 - 13
  • [36] Emtricitabine/tenofovir disoproxil fumarateInterstitial nephritis: case report
    Reactions Weekly, 2011, 1366 (1) : 14 - 14
  • [37] Tenofovir Alafenamide (Vemlidy) for Hepatitis B
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2017, 59 (1511): : 6 - 8
  • [38] Tenofovir Alafenamide for the Treatment of Chronic Hepatitis B Monoinfection
    Childs-Kean, Lindsey M.
    Egelund, Eric F.
    Jourjy, Jacqueline
    PHARMACOTHERAPY, 2018, 38 (10): : 1051 - 1057
  • [39] Emtricitabine/tenofovir disoproxil fumarateInterstitial nephritis: case report
    Reactions Weekly, 2011, 1367 (1) : 18 - 18
  • [40] Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks
    Fung, Scott K.
    Pan, Calvin Q.
    Wong, Grace Lai-Hung
    Seto, Wai-Kay
    Ahn, Sang Hoon
    Chen, Chi-Yi
    Hann, Hie-Won L.
    Jablkowski, Maciej S.
    Kim, Yoon Jun
    Yurdaydin, Cihan
    Peng, Cheng-Yuan
    Nguyen, Tuan
    Yatsuhashi, Hiroshi
    Flaherty, John F.
    Yee, Leland J.
    Abramov, Frida
    Wang, Hongyuan
    Abdurakhmanov, Dzhamal
    Lim, Young-Suk
    Buti, Maria
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (02) : 217 - 229
12345